Terms: = Skin cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
483 results:
1. Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides.
Marques-Piubelli ML; Navarrete J; Ledesma DA; Hudgens CW; Lazcano RN; Alani A; Huen A; Duvic M; Nagarajan P; Aung PP; Wistuba II; Curry JL; Miranda RN; Torres-Cabala CA
Cells; 2024 Feb; 13(5):. PubMed ID: 38474383
[TBL] [Abstract] [Full Text] [Related]
2. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
Chen S; McMiller TL; Soni A; Succaria F; Sidhom JW; Cappelli LC; Casciola-Rosen LA; Morales IR; Sankaran P; Berger AE; Deutsch JS; Zhu QC; Anders RA; Hooper JE; Pardoll DM; Lipson EJ; Taube JM; Topalian SL
J Transl Med; 2024 Mar; 22(1):241. PubMed ID: 38443917
[TBL] [Abstract] [Full Text] [Related]
3. The ever-expanding role of cytokine receptor DR3 in T cells.
Liman N; Lanasa D; Meylan F; Park JH
Cytokine; 2024 Apr; 176():156540. PubMed ID: 38359559
[TBL] [Abstract] [Full Text] [Related]
4. High-dimensional profiling of regulatory T cells in psoriasis reveals an impaired skin-trafficking property.
Lee BH; Bang YJ; Lim SH; Kang SJ; Kim SH; Kim-Schulze S; Park CG; Kim HJ; Kim TG
EBioMedicine; 2024 Feb; 100():104985. PubMed ID: 38306895
[TBL] [Abstract] [Full Text] [Related]
5. skin cancer prevention in extreme sports: Intervention in a 24-h race.
Martínez AR; Pardal CV; Arjona JA; Ruiz FR; Molinero DD; Paulano MR; Subert A; Manzanedo JVG; Cambil Martín J; de Gálvez Aranda MV; López LJ; Sánchez NB; de Troya Martín M
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12940. PubMed ID: 38288775
[TBL] [Abstract] [Full Text] [Related]
6. Combination of vitamin D and photodynamic therapy enhances immune responses in murine models of squamous cell skin cancer.
Anand S; Shen A; Cheng CE; Chen J; Powers J; Rayman P; Diaz M; Hasan T; Maytin EV
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103983. PubMed ID: 38281610
[TBL] [Abstract] [Full Text] [Related]
7. foxp3
Liu X; Zhang W; Han Y; Cheng H; Liu Q; Ke S; Zhu F; Lu Y; Dai X; Wang C; Huang G; Su B; Zou Q; Li H; Zhao W; Xiao L; Lu L; Tong X; Pan F; Li H; Li B
Nat Commun; 2024 Jan; 15(1):122. PubMed ID: 38167862
[TBL] [Abstract] [Full Text] [Related]
8. Celastrol, which targets IL-2/CD25 binding inhibition, induces T cell-mediated antitumor activity in melanoma.
Cho O; Lee JW; Jeong YJ; Kim LK; Jung BK; Heo TH
Eur J Pharmacol; 2024 Jan; 962():176239. PubMed ID: 38043776
[TBL] [Abstract] [Full Text] [Related]
9. foxp3-Positive Cells and Their Contacts with Mast Cells Are Highly Increased in Basal Cell Carcinoma.
Kaukinen AP; Harvima RJ; Harvima IT
Int Arch Allergy Immunol; 2024; 185(2):167-169. PubMed ID: 37989104
[TBL] [Abstract] [Full Text] [Related]
10. LAG3 and TIGIT Expression on Tumor-Infiltrating Lymphocytes in Cutaneous Melanoma.
Naimy S; Bzorek M; Eriksen JO; Løvendorf MB; Litman T; Dyring-Andersen B; Gjerdrum LMR
Dermatology; 2024; 240(1):156-163. PubMed ID: 37952520
[TBL] [Abstract] [Full Text] [Related]
11. Harmine and Kaempferol treatment enhances NFATC1 and foxp3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract] [Full Text] [Related]
12. A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in cancer.
Pinioti S; Sharma H; Flerin NC; Yu Q; Tzoumpa A; Trusso Cafarello S; De Bousser E; Callewaert N; Oldenhove G; Schlenner S; Thienpont B; Garg AD; Di Matteo M; Mazzone M
Cancer Immunol Res; 2023 Dec; 11(12):1611-1629. PubMed ID: 37933083
[TBL] [Abstract] [Full Text] [Related]
13. HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI; Aris M; Panouillot M; Porto M; Dieu-Nosjean MC; Teillaud JL; Barrio MM; Mordoh J
Front Immunol; 2023; 14():1231734. PubMed ID: 37691949
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of the expression of foxp3 and TIGIT in Merkel cell carcinoma.
Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Matsumoto T; Taniguchi M; Kuwamoto S; Umekita Y; Oda Y
Sci Rep; 2023 Aug; 13(1):13114. PubMed ID: 37573372
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.
Mariani P; Torossian N; van Laere S; Vermeulen P; de Koning L; Roman-Roman S; Lantz O; Rodrigues M; Stern MH; Gardrat S; Lesage L; Champenois G; Nicolas A; Matet A; Cassoux N; Servois V; Romano E; Piperno-Neumann S; Lugassy C; Barnhill R
Br J Cancer; 2023 Sep; 129(5):772-781. PubMed ID: 37443346
[TBL] [Abstract] [Full Text] [Related]
16. Co-expression of foxp3 and Helios facilitates the identification of human T regulatory cells in health and disease.
Morina L; Jones ME; Oguz C; Kaplan MJ; Gangaplara A; Fitzhugh CD; Kanakry CG; Shevach EM; Buszko M
Front Immunol; 2023; 14():1114780. PubMed ID: 37350974
[TBL] [Abstract] [Full Text] [Related]
17.
Vaddi PK; Osborne DG; Nicklawsky A; Williams NK; Menon DR; Smith D; Mayer J; Reid A; Domenico J; Nguyen GH; Robinson WA; Ziman M; Gao D; Zhai Z; Fujita M
Front Immunol; 2023; 14():1173035. PubMed ID: 37197667
[TBL] [Abstract] [Full Text] [Related]
18. Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.
Mirjačić Martinović K; Vuletić A; Tišma Miletić N; Nedeljković M; Babović N; Matković S; Jurišić V
Innate Immun; 2023 Apr; 29(3-4):37-44. PubMed ID: 37160888
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T
Marques-Piubelli ML; Seervai RNH; Mudaliar KM; Ma W; Milton DR; Wang J; Muhlbauer A; Parra ER; Solis LM; Nagarajan P; Speiser J; Hudgens C; Cho WC; Aung PP; Patel A; Pacha O; Nelson KC; Tetzlaff MT; Amaria RN; Torres-Cabala CA; Prieto VG; Wistuba II; Curry JL
J Cutan Pathol; 2023 Jul; 50(7):661-673. PubMed ID: 37150813
[TBL] [Abstract] [Full Text] [Related]
20. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments.
Liao P; Jiang M; Islam MS; Wang Y; Chen X
Front Immunol; 2023; 14():1097090. PubMed ID: 36865537
[TBL] [Abstract] [Full Text] [Related]
[Next]
